nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—BRAF—Neuronal System—RASGRF1—refractive error	0.00442	0.00442	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—COL9A1—refractive error	0.00436	0.00436	CbGpPWpGaD
Dabrafenib—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP26A1—refractive error	0.00429	0.00429	CbGpPWpGaD
Dabrafenib—CYP2C8—Oxidation by Cytochrome P450—CYP26A1—refractive error	0.00423	0.00423	CbGpPWpGaD
Dabrafenib—RAF1—Neuronal System—GJD2—refractive error	0.00415	0.00415	CbGpPWpGaD
Dabrafenib—BRAF—Neuronal System—GRIA4—refractive error	0.00411	0.00411	CbGpPWpGaD
Dabrafenib—BRAF—Integrated Breast Cancer Pathway—PML—refractive error	0.00404	0.00404	CbGpPWpGaD
Dabrafenib—RAF1—Transmission across Chemical Synapses—RASGRF1—refractive error	0.00399	0.00399	CbGpPWpGaD
Dabrafenib—BRAF—Neuronal System—KCNJ2—refractive error	0.00394	0.00394	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways in Glioblastoma—PDGFRA—refractive error	0.00392	0.00392	CbGpPWpGaD
Dabrafenib—BRAF—Focal Adhesion—COL2A1—refractive error	0.00391	0.00391	CbGpPWpGaD
Dabrafenib—RAF1—Transmission across Chemical Synapses—GRIA4—refractive error	0.00371	0.00371	CbGpPWpGaD
Dabrafenib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—refractive error	0.00362	0.00362	CbGpPWpGaD
Dabrafenib—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—refractive error	0.00357	0.00357	CbGpPWpGaD
Dabrafenib—RAF1—Senescence and Autophagy in Cancer—BMP2—refractive error	0.00357	0.00357	CbGpPWpGaD
Dabrafenib—RAF1—Transmission across Chemical Synapses—KCNJ2—refractive error	0.00356	0.00356	CbGpPWpGaD
Dabrafenib—SIK1—Circadian rythm related genes—PTEN—refractive error	0.0035	0.0035	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—ROBO3—refractive error	0.00349	0.00349	CbGpPWpGaD
Dabrafenib—CYP2C8—Phase 1 - Functionalization of compounds—CYP26A1—refractive error	0.00348	0.00348	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—COL9A1—refractive error	0.00335	0.00335	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—LAMA2—refractive error	0.00315	0.00315	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	0.00312	0.00312	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—PCCA—refractive error	0.00312	0.00312	CbGpPWpGaD
Dabrafenib—RAF1—TGF-beta Signaling Pathway—PML—refractive error	0.00311	0.00311	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—EBP—refractive error	0.0031	0.0031	CbGpPWpGaD
Dabrafenib—RAF1—Neuronal System—RASGRF1—refractive error	0.00306	0.00306	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—RNF111—refractive error	0.00296	0.00296	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—PAX6—refractive error	0.00291	0.00291	CbGpPWpGaD
Dabrafenib—RAF1—Neuronal System—GRIA4—refractive error	0.00284	0.00284	CbGpPWpGaD
Dabrafenib—RAF1—Signaling of Hepatocyte Growth Factor Receptor—PTEN—refractive error	0.00282	0.00282	CbGpPWpGaD
Dabrafenib—RAF1—BDNF signaling pathway—BMP2—refractive error	0.00277	0.00277	CbGpPWpGaD
Dabrafenib—RAF1—Neuronal System—KCNJ2—refractive error	0.00272	0.00272	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways in Glioblastoma—PDGFRA—refractive error	0.00271	0.00271	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—COL2A1—refractive error	0.0027	0.0027	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—CTSC—refractive error	0.00252	0.00252	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—ROBO3—refractive error	0.00249	0.00249	CbGpPWpGaD
Dabrafenib—BRAF—Regulation of Actin Cytoskeleton—PDGFRA—refractive error	0.00243	0.00243	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—SALL4—refractive error	0.00237	0.00237	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—CACNA1D—refractive error	0.00233	0.00233	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—PML—refractive error	0.00232	0.00232	CbGpPWpGaD
Dabrafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—refractive error	0.0023	0.0023	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by FGFR—PDGFRA—refractive error	0.00227	0.00227	CbGpPWpGaD
Dabrafenib—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—refractive error	0.00227	0.00227	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by FGFR in disease—PDGFRA—refractive error	0.00212	0.00212	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—COL9A1—refractive error	0.00211	0.00211	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	0.00209	0.00209	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PCCA—refractive error	0.00209	0.00209	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—GREM2—refractive error	0.00208	0.00208	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—EBP—refractive error	0.00205	0.00205	CbGpPWpGaD
Dabrafenib—RAF1—Signaling events mediated by Stem cell factor receptor (c-Kit)—PTEN—refractive error	0.00204	0.00204	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways in Glioblastoma—PTEN—refractive error	0.00201	0.00201	CbGpPWpGaD
Dabrafenib—BRAF—Focal Adhesion—PDGFRA—refractive error	0.002	0.002	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—CER1—refractive error	0.00199	0.00199	CbGpPWpGaD
Dabrafenib—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—refractive error	0.00193	0.00193	CbGpPWpGaD
Dabrafenib—BRAF—Disease—DSE—refractive error	0.00192	0.00192	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—BUB1B—refractive error	0.0019	0.0019	CbGpPWpGaD
Dabrafenib—BRAF—NGF signalling via TRKA from the plasma membrane—PDGFRA—refractive error	0.00188	0.00188	CbGpPWpGaD
Dabrafenib—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—refractive error	0.00187	0.00187	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—OR2M7—refractive error	0.00185	0.00185	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—CYP26A1—refractive error	0.00185	0.00185	CbGpPWpGaD
Dabrafenib—CYP2C8—Metapathway biotransformation—CYP26A1—refractive error	0.00182	0.00182	CbGpPWpGaD
Dabrafenib—BRAF—Disease—RDH5—refractive error	0.0018	0.0018	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—EBP—refractive error	0.00178	0.00178	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CHN1—refractive error	0.00177	0.00177	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by SCF-KIT—PDGFRA—refractive error	0.00176	0.00176	CbGpPWpGaD
Dabrafenib—BRAF—Disease—PCCA—refractive error	0.00171	0.00171	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—PML—refractive error	0.00171	0.00171	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IFITM2—refractive error	0.00169	0.00169	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—RNF111—refractive error	0.00169	0.00169	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signaling of activated FGFR—PDGFRA—refractive error	0.00168	0.00168	CbGpPWpGaD
Dabrafenib—RAF1—Regulation of Actin Cytoskeleton—PDGFRA—refractive error	0.00168	0.00168	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—CACNA1D—refractive error	0.00166	0.00166	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB4—PDGFRA—refractive error	0.00166	0.00166	CbGpPWpGaD
Dabrafenib—BRAF—Senescence and Autophagy in Cancer—PTEN—refractive error	0.00165	0.00165	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—PDGFRA—refractive error	0.00165	0.00165	CbGpPWpGaD
Dabrafenib—RAF1—BCR signaling pathway—PTEN—refractive error	0.00164	0.00164	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—TUBB3—refractive error	0.00162	0.00162	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—PML—refractive error	0.00161	0.00161	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signal transduction—PDGFRA—refractive error	0.00158	0.00158	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—OR2M7—refractive error	0.00158	0.00158	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR—PDGFRA—refractive error	0.00157	0.00157	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—VIPR2—refractive error	0.00157	0.00157	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB2—PDGFRA—refractive error	0.00157	0.00157	CbGpPWpGaD
Dabrafenib—BRAF—Disease—IPO5—refractive error	0.00156	0.00156	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 signaling—PDGFRA—refractive error	0.00156	0.00156	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—DSE—refractive error	0.00156	0.00156	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—COL9A1—refractive error	0.00151	0.00151	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 interactions—PDGFRA—refractive error	0.00147	0.00147	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR in disease—PDGFRA—refractive error	0.00147	0.00147	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—PDGFRA—refractive error	0.00147	0.00147	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR—PDGFRA—refractive error	0.00145	0.00145	CbGpPWpGaD
Dabrafenib—BRAF—Disease—WNT10A—refractive error	0.00145	0.00145	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—PDGFRA—refractive error	0.00144	0.00144	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—GREM2—refractive error	0.00144	0.00144	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR in Cancer—PDGFRA—refractive error	0.00144	0.00144	CbGpPWpGaD
Dabrafenib—BRAF—PDGFR-beta signaling pathway—PTEN—refractive error	0.00144	0.00144	CbGpPWpGaD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—TUBB3—refractive error	0.00144	0.00144	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—CTSC—refractive error	0.00143	0.00143	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—PDGFRA—refractive error	0.00143	0.00143	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways in Glioblastoma—PTEN—refractive error	0.00139	0.00139	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PLA2G16—refractive error	0.00139	0.00139	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PCCA—refractive error	0.00139	0.00139	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—PDGFRA—refractive error	0.00138	0.00138	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—EBP—refractive error	0.00138	0.00138	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—PDGFRA—refractive error	0.00138	0.00138	CbGpPWpGaD
Dabrafenib—BRAF—Disease—RNF111—refractive error	0.00137	0.00137	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—VIPR2—refractive error	0.00134	0.00134	CbGpPWpGaD
Dabrafenib—RAF1—Disease—DSE—refractive error	0.00133	0.00133	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—PDGFRA—refractive error	0.00132	0.00132	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—PDGFRA—refractive error	0.0013	0.0013	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—EBP—refractive error	0.00128	0.00128	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—RDH5—refractive error	0.00126	0.00126	CbGpPWpGaD
Dabrafenib—RAF1—Disease—RDH5—refractive error	0.00125	0.00125	CbGpPWpGaD
Dabrafenib—BRAF—Integrated Breast Cancer Pathway—PTEN—refractive error	0.00124	0.00124	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CHN1—refractive error	0.00123	0.00123	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PCCA—refractive error	0.0012	0.0012	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	0.0012	0.0012	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—TUBB3—refractive error	0.0012	0.0012	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—AXL—refractive error	0.0012	0.0012	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—WNT10A—refractive error	0.00119	0.00119	CbGpPWpGaD
Dabrafenib—BRAF—Disease—LUM—refractive error	0.00118	0.00118	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PCCA—refractive error	0.00118	0.00118	CbGpPWpGaD
Dabrafenib—BRAF—EGF/EGFR Signaling Pathway—PTEN—refractive error	0.00117	0.00117	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by FGFR—PTEN—refractive error	0.00117	0.00117	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—TUBB3—refractive error	0.00116	0.00116	CbGpPWpGaD
Dabrafenib—RAF1—Senescence and Autophagy in Cancer—PTEN—refractive error	0.00114	0.00114	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—VANGL2—refractive error	0.00109	0.00109	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—PML—refractive error	0.00109	0.00109	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—OR2M7—refractive error	0.00109	0.00109	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—TUBB3—refractive error	0.00109	0.00109	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by FGFR in disease—PTEN—refractive error	0.00109	0.00109	CbGpPWpGaD
Dabrafenib—RAF1—Disease—IPO5—refractive error	0.00108	0.00108	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—DSE—refractive error	0.00105	0.00105	CbGpPWpGaD
Dabrafenib—BRAF—Focal Adhesion—PTEN—refractive error	0.00103	0.00103	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—RNF111—refractive error	0.00102	0.00102	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—WNT10A—refractive error	0.00102	0.00102	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—TUBB3—refractive error	0.00101	0.00101	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—PAX6—refractive error	0.00101	0.00101	CbGpPWpGaD
Dabrafenib—RAF1—Disease—WNT10A—refractive error	0.001	0.001	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—PDGFRA—refractive error	0.000999	0.000999	CbGpPWpGaD
Dabrafenib—RAF1—PDGFR-beta signaling pathway—PTEN—refractive error	0.000994	0.000994	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—CYP26A1—refractive error	0.000991	0.000991	CbGpPWpGaD
Dabrafenib—CYP3A4—Metapathway biotransformation—CYP26A1—refractive error	0.000977	0.000977	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—DSE—refractive error	0.000969	0.000969	CbGpPWpGaD
Dabrafenib—BRAF—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	0.000963	0.000963	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—LUM—refractive error	0.000962	0.000962	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—PDGFRA—refractive error	0.000959	0.000959	CbGpPWpGaD
Dabrafenib—BRAF—Disease—RPS27—refractive error	0.000958	0.000958	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—RNF111—refractive error	0.000956	0.000956	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CER1—refractive error	0.000956	0.000956	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TJP2—refractive error	0.000956	0.000956	CbGpPWpGaD
Dabrafenib—RAF1—Disease—RNF111—refractive error	0.000945	0.000945	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PCCA—refractive error	0.000932	0.000932	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PLA2G16—refractive error	0.000932	0.000932	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—VIPR2—refractive error	0.000928	0.000928	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—CACNA1D—refractive error	0.000926	0.000926	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by SCF-KIT—PTEN—refractive error	0.000903	0.000903	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—refractive error	0.000896	0.000896	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—RDH5—refractive error	0.000873	0.000873	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CTSC—refractive error	0.00087	0.00087	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signaling of activated FGFR—PTEN—refractive error	0.000864	0.000864	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PLA2G16—refractive error	0.000863	0.000863	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PCCA—refractive error	0.000863	0.000863	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB4—PTEN—refractive error	0.00085	0.00085	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—PTEN—refractive error	0.000845	0.000845	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—AXL—refractive error	0.000828	0.000828	CbGpPWpGaD
Dabrafenib—RAF1—Disease—LUM—refractive error	0.000819	0.000819	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—CYP26A1—refractive error	0.000818	0.000818	CbGpPWpGaD
Dabrafenib—RAF1—Insulin Signaling—PTEN—refractive error	0.000816	0.000816	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signal transduction—PTEN—refractive error	0.000812	0.000812	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR—PTEN—refractive error	0.000808	0.000808	CbGpPWpGaD
Dabrafenib—RAF1—EGF/EGFR Signaling Pathway—PTEN—refractive error	0.000808	0.000808	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB2—PTEN—refractive error	0.000804	0.000804	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 signaling—PTEN—refractive error	0.0008	0.0008	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—EBP—refractive error	0.000793	0.000793	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—VANGL2—refractive error	0.000757	0.000757	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 interactions—PTEN—refractive error	0.000753	0.000753	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	0.000753	0.000753	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR in disease—PTEN—refractive error	0.000753	0.000753	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR—PTEN—refractive error	0.000746	0.000746	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—PTEN—refractive error	0.000741	0.000741	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR in Cancer—PTEN—refractive error	0.000739	0.000739	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—PTEN—refractive error	0.000736	0.000736	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—COL9A1—refractive error	0.000725	0.000725	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—PTEN—refractive error	0.000711	0.000711	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	0.000708	0.000708	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—WNT10A—refractive error	0.000704	0.000704	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—EBP—refractive error	0.000691	0.000691	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	0.000667	0.000667	CbGpPWpGaD
Dabrafenib—RAF1—Disease—RPS27—refractive error	0.000662	0.000662	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—RNF111—refractive error	0.000662	0.000662	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CER1—refractive error	0.000662	0.000662	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TJP2—refractive error	0.000662	0.000662	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—refractive error	0.00065	0.00065	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—LUM—refractive error	0.000646	0.000646	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—CACNA1D—refractive error	0.000622	0.000622	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—DSE—refractive error	0.000601	0.000601	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—LUM—refractive error	0.000598	0.000598	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—CACNA1D—refractive error	0.000576	0.000576	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—PDGFRA—refractive error	0.00057	0.00057	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—PML—refractive error	0.000557	0.000557	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—CYP26A1—refractive error	0.000549	0.000549	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—PDGFRA—refractive error	0.000547	0.000547	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—TUBB3—refractive error	0.000546	0.000546	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PLA2G16—refractive error	0.000536	0.000536	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PCCA—refractive error	0.000536	0.000536	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—DSE—refractive error	0.000524	0.000524	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—PTEN—refractive error	0.000513	0.000513	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—CYP26A1—refractive error	0.000509	0.000509	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—COL9A1—refractive error	0.000501	0.000501	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—BMP2—refractive error	0.000497	0.000497	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—PTEN—refractive error	0.000492	0.000492	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PCCA—refractive error	0.000467	0.000467	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PLA2G16—refractive error	0.000467	0.000467	CbGpPWpGaD
Dabrafenib—BRAF—Disease—PDGFRA—refractive error	0.000443	0.000443	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—EBP—refractive error	0.000426	0.000426	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—refractive error	0.000415	0.000415	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—LUM—refractive error	0.000371	0.000371	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CACNA1D—refractive error	0.000357	0.000357	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—BMP2—refractive error	0.000344	0.000344	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	0.000334	0.000334	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—PDGFRA—refractive error	0.000332	0.000332	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—LUM—refractive error	0.000324	0.000324	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—DSE—refractive error	0.000323	0.000323	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CYP26A1—refractive error	0.000316	0.000316	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CACNA1D—refractive error	0.000311	0.000311	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—PDGFRA—refractive error	0.00031	0.00031	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PDGFRA—refractive error	0.000306	0.000306	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—PTEN—refractive error	0.000292	0.000292	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PCCA—refractive error	0.000288	0.000288	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PLA2G16—refractive error	0.000288	0.000288	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—PTEN—refractive error	0.000281	0.000281	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—refractive error	0.000279	0.000279	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CYP26A1—refractive error	0.000275	0.000275	CbGpPWpGaD
Dabrafenib—BRAF—Disease—PTEN—refractive error	0.000227	0.000227	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PDGFRA—refractive error	0.000214	0.000214	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—LUM—refractive error	0.000199	0.000199	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CACNA1D—refractive error	0.000192	0.000192	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PTEN—refractive error	0.000185	0.000185	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—PTEN—refractive error	0.00017	0.00017	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CYP26A1—refractive error	0.000169	0.000169	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—refractive error	0.00016	0.00016	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—PTEN—refractive error	0.000159	0.000159	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PTEN—refractive error	0.000157	0.000157	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PTEN—refractive error	0.000124	0.000124	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PTEN—refractive error	0.000115	0.000115	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PTEN—refractive error	0.00011	0.00011	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PTEN—refractive error	7.13e-05	7.13e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PTEN—refractive error	6.21e-05	6.21e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PTEN—refractive error	3.83e-05	3.83e-05	CbGpPWpGaD
